Unique ID issued by UMIN | UMIN000047874 |
---|---|
Receipt number | R000052191 |
Scientific Title | Examination of the relationship between acute kidney injury and intraoperative infusion preparation in liver resection |
Date of disclosure of the study information | 2022/05/27 |
Last modified on | 2022/05/27 13:21:53 |
Examination of the relationship between acute kidney injury and intraoperative infusion preparation in liver resection
Examination of the relationship between acute kidney injury and intraoperative infusion preparation in liver resection
Examination of the relationship between acute kidney injury and intraoperative infusion preparation in liver resection
Examination of the relationship between acute kidney injury and intraoperative infusion preparation in liver resection
Japan |
Liver tumor
Hepato-biliary-pancreatic surgery |
Malignancy
NO
In liver surgery, limiting the amount of intraoperative fluid can reduce central venous pressure and reduce bleeding from the cut surface of the liver. By using HES, it is possible to maintain oncotic pressure while limiting the amount of infusion, and it is expected that bleeding will be suppressed. On the other hand, HES has been pointed out to cause AKI in septic patients, but the incidence of postoperative AKI when used in scheduled surgery patients is not clear. HES will be used in liver surgery, which has a relatively high incidence of postoperative AKI of about 20%, and the incidence of AKI will be examined.
Safety,Efficacy
Acute kidney injury
Postoperative complications
Interventional
Cross-over
Randomized
Individual
Open -no one is blinded
Active
2
Treatment
Medicine |
Intraoperative infusion management is performed with Ringer's bicarbonate solution alone. Blood transfusion should be done at Hb 8.0g / dL or less or Ht 25% or less
Intraoperative fluid management is performed with HES alone. Blood transfusion should be done at Hb 8.0g / dL or less or Ht 25% or less
20 | years-old | <= |
100 | years-old | >= |
Male and Female
Patients scheduled to undergo liver resection surgery during hospitalization at our hospital.
The age at the time of registration is 20 years or older.
Written consent has been obtained from the research subjects themselves for participation in the research.
Patients who are contraindicated for administration of HES preparation.
Research subjects who are judged by the principal investigator or the doctor in charge to be inappropriate for conducting this study safely.
150
1st name | Yusuke |
Middle name | |
Last name | Kusaka |
Osaka Medical and Pharmaceutical University Hospital
Department of Anesthesiology
569-8686
2-7 Daigakumachi, Takatsuki City, Osaka Prefecture
072-683-1221
yuusuke.kusaka@ompu.ac.jp
1st name | Hiroyuki |
Middle name | |
Last name | Yamazaki |
Osaka Medical and Pharmaceutical University Hospital
Department of Anesthesiology
569-8686
2-7 Daigakumachi, Takatsuki City, Osaka Prefecture
072-683-1221
hiroyuki.yamazaki@ompu.ac.jp
Osaka Medical and Pharmaceutical University Hospital
No
Other
Osaka Medical and Pharmaceutical University Hospital
Osaka Medical and Pharmaceutical University Hospital
072-683-1221
rinri@ompu.ac.jp
NO
2022 | Year | 05 | Month | 27 | Day |
Partially published
Open public recruiting
2021 | Year | 07 | Month | 27 | Day |
2021 | Year | 09 | Month | 14 | Day |
2021 | Year | 09 | Month | 14 | Day |
2024 | Year | 03 | Month | 31 | Day |
2022 | Year | 05 | Month | 27 | Day |
2022 | Year | 05 | Month | 27 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000052191